| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.5 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.032 | 0.6 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |